Murakawa, Y.
209  results:
Search for persons X
?
1

Long-term outcomes of Japan-specific dosage of rivaroxaban ..:

Ikeda, T ; Ogawa, S ; Kitazono, T...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
2

P1865Incidence and predictors of invasively-treated pericar..:

Murakawa, Y ; Yamane, T ; Goya, M...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
 
?
4

1162Predictors of serious complications during and immediat..:

Murakawa, Y. ; Yamane, T. ; Inoue, K....
EP Europace.  19 (2017)  suppl_3 - p. iii247-iii247 , 2017
 
?
6

Oral anticoagulation therapy during catheter ablation for a..:

Murakawa, Y. ; Nogami, A. ; Shoda, M....
European Heart Journal.  34 (2013)  suppl 1 - p. P527-P527 , 2013
 
?
7

Elevated BAFF Levels in the Cerebrospinal Fluid of Patients..:

Sumita, Y. ; Murakawa, Y. ; Sugiura, T....
Scandinavian Journal of Immunology.  75 (2012)  6 - p. 633-640 , 2012
 
?
8

Bone fragility in male glucocorticoid-induced osteoporosis ..:

Hayashi, K. ; Yamamoto, M. ; Murakawa, Y....
Osteoporosis International.  20 (2009)  11 - p. 1889-1894 , 2009
 
?
9

Effect of alendronate on bone metabolic indices and bone mi..:

Kaji, H. ; Kuroki, Y. ; Murakawa, Y....
Osteoporosis International.  21 (2009)  9 - p. 1565-1571 , 2009
 
?
10

Chemokine-like factor expression in the idiopathic inflamma..:

Chowdhury, M. H. ; Nagai, A. ; Terashima, M....
Acta Neurologica Scandinavica.  118 (2008)  2 - p. 106-114 , 2008
 
?
11

T cell interactions in active rheumatoid arthritis: insight..:

SAKANE, T ; MURAKAWA, Y ; TAKENO, M...
Clinical and Experimental Immunology.  85 (2008)  1 - p. 55-60 , 2008
 
?
13

The preventive and therapeutic effects of GCPII (NAALADase)..:

Zhang, W. ; Murakawa, Y. ; Wozniak, K.M...
Journal of the Neurological Sciences.  247 (2006)  2 - p. 217-223 , 2006
 
?
 
1-15